Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Copaxone, Glatopa
Glatrimer acetate is an immunomodulator used to treat relapsing-remitting multiple sclerosis (MS). It is a synthetic polypeptide that works by mimicking myelin basic protein, a component of the myelin sheath that protects nerve fibers. While the exact mechanism isn't fully understood, it is thought to modify immune processes believed to be responsible for MS.
For reducing the frequency of relapses in relapsing-remitting multiple sclerosis.
Outcome:
Bleeding complications
Mechanism:
Synergistic effects on coagulation cascade
Outcome:
Increased risk of infection
Mechanism:
Immunosuppression
Outcome:
Generally safe
Mechanism:
Unknown
Most likely new formulation: Extended-release injectable formulation (Year 2025, 80% confidence)
Based on current usage trends and clinical trial data, Glatrimer acetate is expected to maintain its current market share for the treatment of relapsing-remitting MS, with a 70% likelihood of remaining a first-line treatment option for the next 5 years.
Immunomodulator, Disease-modifying therapy (DMT)
Synthetic polypeptide